3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Paraparesis, Tropical Spastic
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
Infections
1
HTLV-I Infections
1
Epstein-Barr Virus Infections
1
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Tenofovir
×
1 year
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled